Weichang'an Formula Inhibits Tumor Growth in Combination with Bevacizumab in a Murine Model of Colon Cancer-Making up for the Deficiency of Bevacizumab by inhibiting VEGFR-1

• Autori principali: Chuan-Fang Pan (Autore), Xi Zhang (Autore), Jing-Wen Wang (Autore), Tao Yang (Autore), Linda L. D. Zhong (Autore), Ke-Ping Shen (Autore)
• Natura: Libro
• Pubblicazione: Frontiers Media S.A., 2020-11-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Aim: Angiogenesis plays an important role in the initiation, development, and metastasis of malignant tumors. Antiangiogenic drugs combined with immune therapy are considered to have a synergistic effect on anti-tumor strategy. Weichang'an formula (WCAF) is a prescription of traditional Chinese...